Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2020 from OUS - Addiction Treatment Research Units

18 publications found

Bech AB, Clausen T, Waal H, Vindenes V, Edvardsen HE, Frost J, Skeie I (2020)
Post-mortem toxicological analyses of blood samples from 107 patients receiving opioid agonist treatment: substances detected and pooled opioid and benzodiazepine concentrations
Addiction
DOI 10.1111/add.15211, PubMed 32738014

Bukten A, Lund IO, Kinner SA, Rognli EB, Havnes IA, Muller AE, Stavseth MR (2020)
Factors associated with drug use in prison - results from the Norwegian offender mental health and addiction (NorMA) study
Health Justice, 8 (1), 10
DOI 10.1186/s40352-020-00112-8, PubMed 32399643

Ellingsen MM, Johannesen SL, Martinsen EW, Dahl SR, Hallgren M (2020)
Effects of Acute Exercise on Drug Craving, Self-Esteem, Mood, and Affect in Adults with Polysubstance Use Disorder: Protocol for a Multicenter Randomized Controlled Trial
JMIR Res Protoc, 9 (10), e18553
DOI 10.2196/18553, PubMed 33048056

Gatti F, Walderhaug E, Kern-Godal A, Lysell J, Arnevik EA (2020)
Complementary horse-assisted therapy for substance use disorders: a randomized controlled trial
Addict Sci Clin Pract, 15 (1), 7
DOI 10.1186/s13722-020-0183-z, PubMed 32019584

Hauger LE, Westlye LT, Bjørnebekk A (2020)
Anabolic androgenic steroid dependence is associated with executive dysfunction
Drug Alcohol Depend, 208, 107874
DOI 10.1016/j.drugalcdep.2020.107874, PubMed 31972519

Havnes IA, Bukten A, Rognli EB, Muller AE (2020)
Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study
Drug Alcohol Depend, 217, 108255
DOI 10.1016/j.drugalcdep.2020.108255, PubMed 32949884

Havnes IA, Jørstad ML, Innerdal I, Bjørnebekk A (2020)
Anabolic-androgenic steroid use among women - A qualitative study on experiences of masculinizing, gonadal and sexual effects
Int J Drug Policy, 102876 (in press)
DOI 10.1016/j.drugpo.2020.102876, PubMed 32736958

Havnes IA, Jørstad ML, McVeigh J, Van Hout MC, Bjørnebekk A (2020)
The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment
Subst Abuse, 14, 1178221820904150
DOI 10.1177/1178221820904150, PubMed 32127749

Medved D, Clausen T, Bukten A, Bjørnestad R, Muller AE (2020)
Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients
Subst Abuse Treat Prev Policy, 15 (1), 87
DOI 10.1186/s13011-020-00311-4, PubMed 33198799

Mutsaerts HJMM, Petr J, Groot P, Vandemaele P, Ingala S, Robertson AD, Václavů L, Groote I, Kuijf H, Zelaya F, O'Daly O, Hilal S, Wink AM, Kant I, Caan MWA, Morgan C, de Bresser J, Lysvik E, Schrantee A, Bjørnebekk A, Clement P, Shirzadi Z, Kuijer JPA, Wottschel V, Anazodo UC et al. (2020)
ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies
Neuroimage, 219, 117031
DOI 10.1016/j.neuroimage.2020.117031, PubMed 32526385

Paap MCS, Hummelen B, Braeken J, Arnevik EA, Walderhaug E, Wilberg T, Berghuis H, Hutsebaut J, Pedersen G (2020)
A multi-center psychometric evaluation of the Severity Indices of Personality Problems 118 (SIPP-118): Do we really need all those facets?
Qual Life Res, 30 (2), 567-575
DOI 10.1007/s11136-020-02654-8, PubMed 33029679

Pape H, Rossow I, Bukten A (2020)
Alcohol Problems among Prisoners: Subgroup Variations, Concurrent Drug Problems, and Treatment Needs
Eur Addict Res
DOI 10.1159/000511253, PubMed 33321498

Rand K, Arnevik EA, Walderhaug E (2020)
Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L
J Patient Rep Outcomes, 4 (1), 92
DOI 10.1186/s41687-020-00247-0, PubMed 33165764

Solli KK, Opheim A, Latif ZE, Krajci P, Benth JŠ, Kunoe N, Tanum L (2020)
Adapting treatment length to opioid-dependent individuals' needs and preferences: A 2-year follow-up to a 1-year study of extended-release naltrexone
Addiction
DOI 10.1111/add.15378, PubMed 33338285

Tonga JB, Eilertsen DE, Solem IKL, Arnevik EA, Korsnes MS, Ulstein ID (2020)
Effect of Self-Efficacy on Quality of Life in People With Mild Cognitive Impairment and Mild Dementia: The Mediating Roles of Depression and Anxiety
Am J Alzheimers Dis Other Demen, 35, 1533317519885264
DOI 10.1177/1533317519885264, PubMed 31916847

Tonga JB, Šaltytė Benth J, Arnevik EA, Werheid K, Korsnes MS, Ulstein ID (2020)
Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: a randomized controlled trial
Int Psychogeriatr, 1-15 (in press)
DOI 10.1017/S1041610220000216, PubMed 32131911

Vaskinn A, Hauger LE, Bjørnebekk A (2020)
Theory of mind in users of anabolic androgenic steroids
Psychopharmacology (Berl), 237 (10), 3191-3199
DOI 10.1007/s00213-020-05603-y, PubMed 32623552

Welle-Strand GK, Skurtveit S, Abel KF, Chalabianloo F, Sarfi M (2020)
Living a normal life? Follow-up study of women who had been in opioid maintenance treatment during pregnancy
J Subst Abuse Treat, 113, 108004
DOI 10.1016/j.jsat.2020.108004, PubMed 32359675

 
Page visits: 534998